Dallas Fort Worth Injury Lawyer Blog
As a Dallas Fort Worth Asbestos Mesothelioma Attorney, I am providing this promising new cancer regimen for devastating mesothelioma disease.
Southwest Oncology Group (SWOG), a consortium of 19 cancer testing centers, is in the process of conducting Phase 1/Phase 2 trials on the use of cediranib maleate in combination with pemetrexed disodium (marketed as Alimta) and cisplatin to treat mesothelioma patients who have not received previous chemotherapy treatment.
Mesothelioma is caused by inhaling or ingesting asbestos fibers. At least 2,500 Americans are diagnosed with this deadly disease each year, most in the final stages. A typical prognosis for mesothelioma, at this stage, is about a year to live.
Mesothelioma, which occurs in 3 out of 4 cases in the mesothelial lining around the lungs, is often treated with surgery, radiation and chemotherapy, or a combination of, but most treatments are considered palliative rather than curative. That is, they reduce pain and improve breathing, but in most cases do not extend lifetimes beyond a few months at best. Pemetrexed and cisplatin, a platinum-based compound, are the chemicals of choice for treating mesothelioma.
The addition of cediranib maleate (sometimes called AZD2171, or Recentin), because of its ability to block the delivery of needed enzymes and blood to cancer cells, is expected to improve the performance of the Alimta/cisplatin package of chemotherapy agents.
Information and commentary provided by Dallas Fort Worth Personal Injury Attorney Dr Shezad Malik. The Dr Shezad Malik Law Firm can be contacted in Dallas toll free at 214-390-3189. If you or a loved one has been injured from Asbestos, or Mesothelioma please fill out our contact card for a free consultation.